NSAIDs (no. 103) | DPT+ | DPT- | DPT Alt. Neg | DPT ASA- | DPT ASA+ | DPT COX2 selective - | DPT n.p. |
---|---|---|---|---|---|---|---|
Anaphylaxis (no. 15) | – | 2/15 (13.3%) | 1/15 (6.7%) | 3/15 (20%) | 1/15 (6.7%) | 1/15 (6.7%) | 8/15 (53.3%) |
Skin Reactions (no. 82) | 9/82 (11%) | 58/82 (70.7%) | 5/82 (6.1%) | 4/82 (4.9%) | 4/82 (4.9%) | 4/82 (4.9%) | 10/82 (12.2%) |
Respiratory Symptoms (no. 4) | |||||||
-Cough (no. 2) | – | 2/4 (50%) | – | – | 1/4 (25%) | 1/4 (25%) | 1/4 (25%) |
-Bronchospasm (no. 2) | |||||||
Seizures (no. 1) | – | 1/1 (100%) | – | – | – | – | – |
Hypotension (no. 1) | – | 1/1 (100%) | – | – | – | – | – |